EMEA (Europe, Middle East and Africa) Biodefense Market Report 2017

August 2017 | 119 pages | ID: EF471DF3ED9EN
QYResearch

Abstracts

In this report, the EMEA Biodefense market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Biodefense for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biodefense market competition by top manufacturers/players, with Biodefense sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Emergent Biosolutions
• Hytest
• GSK
• Sanofi
• PharmAthene
• Bavarian Nordic
• SIGA Technologies
• Arbutus Biopharma
• DynPort Vaccine
• Xoma Corporation
• Ichor Medical Systems
• Aeolus Pharmaceuticals
• Achaogen
• Elusys Therapeutics
• Dynavax Technologies
• Cleveland BioLabs
• Soligenix
• Alnylam Pharmaceuticals

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Anthrax
• Smallpox
• Botulism
• Radiation/Nuclear

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Biodefense for each application, including

• Industry
• Chemical

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Biodefense Market Report 2017

1 BIODEFENSE OVERVIEW

1.1 Product Overview and Scope of Biodefense
1.2 Classification of Biodefense
  1.2.1 EMEA Biodefense Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Biodefense Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Anthrax
  1.2.4 Smallpox
  1.2.5 Botulism
  1.2.6 Radiation/Nuclear
1.3 EMEA Biodefense Market by Application/End Users
  1.3.1 EMEA Biodefense Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Industry
  1.3.3 Chemical
1.4 EMEA Biodefense Market by Region
  1.4.1 EMEA Biodefense Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biodefense (2012-2022)
  1.5.1 EMEA Biodefense Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Biodefense Revenue and Growth Rate (2012-2022)

2 EMEA BIODEFENSE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Biodefense Market Competition by Players/Manufacturers
  2.1.1 EMEA Biodefense Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Biodefense Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Biodefense Sale Price by Players (2012-2017)
2.2 EMEA Biodefense (Volume and Value) by Type/Product Category
  2.2.1 EMEA Biodefense Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Biodefense Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Biodefense Sale Price by Type (2012-2017)
2.3 EMEA Biodefense (Volume) by Application
2.4 EMEA Biodefense (Volume and Value) by Region
  2.4.1 EMEA Biodefense Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Biodefense Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Biodefense Sales Price by Region (2012-2017)

3 EUROPE BIODEFENSE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Biodefense Sales and Value (2012-2017)
  3.1.1 Europe Biodefense Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Biodefense Revenue and Growth Rate (2012-2017)
3.2 Europe Biodefense Sales and Market Share by Type
3.3 Europe Biodefense Sales and Market Share by Application
3.4 Europe Biodefense Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Biodefense Sales Volume by Countries (2012-2017)
  3.4.2 Europe Biodefense Revenue by Countries (2012-2017)
  3.4.3 Germany Biodefense Sales and Growth Rate (2012-2017)
  3.4.4 France Biodefense Sales and Growth Rate (2012-2017)
  3.4.5 UK Biodefense Sales and Growth Rate (2012-2017)
  3.4.6 Russia Biodefense Sales and Growth Rate (2012-2017)
  3.4.7 Italy Biodefense Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Biodefense Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BIODEFENSE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Biodefense Sales and Value (2012-2017)
  4.1.1 Middle East Biodefense Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Biodefense Revenue and Growth Rate (2012-2017)
4.2 Middle East Biodefense Sales and Market Share by Type
4.3 Middle East Biodefense Sales and Market Share by Application
4.4 Middle East Biodefense Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Biodefense Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Biodefense Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Biodefense Sales and Growth Rate (2012-2017)
  4.4.4 Israel Biodefense Sales and Growth Rate (2012-2017)
  4.4.5 UAE Biodefense Sales and Growth Rate (2012-2017)
  4.4.6 Iran Biodefense Sales and Growth Rate (2012-2017)

5 AFRICA BIODEFENSE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Biodefense Sales and Value (2012-2017)
  5.1.1 Africa Biodefense Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Biodefense Revenue and Growth Rate (2012-2017)
5.2 Africa Biodefense Sales and Market Share by Type
5.3 Africa Biodefense Sales and Market Share by Application
5.4 Africa Biodefense Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Biodefense Sales Volume by Countries (2012-2017)
  5.4.2 Africa Biodefense Revenue by Countries (2012-2017)
  5.4.3 South Africa Biodefense Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Biodefense Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Biodefense Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Biodefense Sales and Growth Rate (2012-2017)

6 EMEA BIODEFENSE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Emergent Biosolutions
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biodefense Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Hytest
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Biodefense Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Hytest Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Biodefense Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Biodefense Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 PharmAthene
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Biodefense Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bavarian Nordic
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Biodefense Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 SIGA Technologies
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Biodefense Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Arbutus Biopharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Biodefense Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 DynPort Vaccine
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Biodefense Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Xoma Corporation
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Biodefense Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Ichor Medical Systems
6.12 Aeolus Pharmaceuticals
6.13 Achaogen
6.14 Elusys Therapeutics
6.15 Dynavax Technologies
6.16 Cleveland BioLabs
6.17 Soligenix
6.18 Alnylam Pharmaceuticals

7 BIODEFENSE MANUFACTURING COST ANALYSIS

7.1 Biodefense Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biodefense

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biodefense Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biodefense Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BIODEFENSE MARKET FORECAST (2017-2022)

11.1 EMEA Biodefense Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Biodefense Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Biodefense Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Biodefense Price and Trend Forecast (2017-2022)
11.2 EMEA Biodefense Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biodefense Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biodefense Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biodefense Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biodefense Sales Forecast by Type (2017-2022)
11.7 EMEA Biodefense Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biodefense
Figure EMEA Biodefense Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Biodefense Sales Volume Market Share by Type (Product Category) in 2016
Figure Anthrax Product Picture
Figure Smallpox Product Picture
Figure Botulism Product Picture
Figure Radiation/Nuclear Product Picture
Figure EMEA Biodefense Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Biodefense by Application in 2016
Figure Industry Examples
Table Key Downstream Customer in Industry
Figure Chemical Examples
Table Key Downstream Customer in Chemical
Figure EMEA Biodefense Market Size (Million USD) by Region (2012-2022)
Figure Europe Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biodefense Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biodefense Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biodefense Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biodefense Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biodefense Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biodefense Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Biodefense Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Biodefense Sales Share by Players (2012-2017)
Figure 2016 Biodefense Sales Share by Players
Figure 2017 Biodefense Sales Share by Players
Figure EMEA Biodefense Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biodefense Revenue (Million USD) by Players (2012-2017)
Table EMEA Biodefense Revenue Share by Players (2012-2017)
Table 2016 EMEA Biodefense Revenue Share by Players
Table 2017 EMEA Biodefense Revenue Share by Players
Table EMEA Biodefense Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Biodefense Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Biodefense Sales Share by Type (2012-2017)
Figure Sales Market Share of Biodefense by Type (2012-2017)
Figure EMEA Biodefense Sales Market Share by Type (2012-2017)
Table EMEA Biodefense Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biodefense Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biodefense by Type in 2016
Table EMEA Biodefense Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Biodefense Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Biodefense Sales Share by Application (2012-2017)
Figure Sales Market Share of Biodefense by Application (2012-2017)
Figure EMEA Biodefense Sales Market Share by Application in 2016
Table EMEA Biodefense Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Biodefense Sales Share by Region (2012-2017)
Figure Sales Market Share of Biodefense by Region (2012-2017)
Figure EMEA Biodefense Sales Market Share in 2016
Table EMEA Biodefense Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biodefense Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biodefense by Region (2012-2017)
Figure EMEA Biodefense Revenue Market Share Regions in 2016
Table EMEA Biodefense Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Biodefense Revenue and Growth Rate (2012-2017)
Table Europe Biodefense Sales (K MT) by Type (2012-2017)
Table Europe Biodefense Market Share by Type (2012-2017)
Figure Europe Biodefense Market Share by Type in 2016
Table Europe Biodefense Sales (K MT) by Application (2012-2017)
Table Europe Biodefense Market Share by Application (2012-2017)
Figure Europe Biodefense Market Share by Application in 2016
Table Europe Biodefense Sales (K MT) by Countries (2012-2017)
Table Europe Biodefense Sales Market Share by Countries (2012-2017)
Figure Europe Biodefense Sales Market Share by Countries (2012-2017)
Figure Europe Biodefense Sales Market Share by Countries in 2016
Table Europe Biodefense Revenue (Million USD) by Countries (2012-2017)
Table Europe Biodefense Revenue Market Share by Countries (2012-2017)
Figure Europe Biodefense Revenue Market Share by Countries (2012-2017)
Figure Europe Biodefense Revenue Market Share by Countries in 2016
Figure Germany Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure France Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure UK Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biodefense Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biodefense Sales (K MT) by Type (2012-2017)
Table Middle East Biodefense Market Share by Type (2012-2017)
Figure Middle East Biodefense Market Share by Type (2012-2017)
Table Middle East Biodefense Sales (K MT) by Applications (2012-2017)
Table Middle East Biodefense Market Share by Applications (2012-2017)
Figure Middle East Biodefense Sales Market Share by Application in 2016
Table Middle East Biodefense Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Biodefense Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biodefense Sales Volume Market Share by Countries in 2016
Table Middle East Biodefense Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biodefense Revenue Market Share by Countries (2012-2017)
Figure Middle East Biodefense Revenue Market Share by Countries (2012-2017)
Figure Middle East Biodefense Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biodefense Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biodefense Sales (K MT) by Type (2012-2017)
Table Africa Biodefense Sales Market Share by Type (2012-2017)
Figure Africa Biodefense Sales Market Share by Type (2012-2017)
Figure Africa Biodefense Sales Market Share by Type in 2016
Table Africa Biodefense Sales (K MT) by Application (2012-2017)
Table Africa Biodefense Sales Market Share by Application (2012-2017)
Figure Africa Biodefense Sales Market Share by Application (2012-2017)
Table Africa Biodefense Sales Volume (K MT) by Countries (2012-2017)
Table Africa Biodefense Sales Market Share by Countries (2012-2017)
Figure Africa Biodefense Sales Market Share by Countries (2012-2017)
Figure Africa Biodefense Sales Market Share by Countries in 2016
Table Africa Biodefense Revenue (Million USD) by Countries (2012-2017)
Table Africa Biodefense Revenue Market Share by Countries (2012-2017)
Figure Africa Biodefense Revenue Market Share by Countries (2012-2017)
Figure Africa Biodefense Revenue Market Share by Countries in 2016
Figure South Africa Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Biodefense Sales (K MT) and Growth Rate (2012-2017)
Table Emergent Biosolutions Biodefense Basic Information List
Table Emergent Biosolutions Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Emergent Biosolutions Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Emergent Biosolutions Biodefense Sales Market Share in EMEA (2012-2017)
Figure Emergent Biosolutions Biodefense Revenue Market Share in EMEA (2012-2017)
Table Hytest Biodefense Basic Information List
Table Hytest Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hytest Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Hytest Biodefense Sales Market Share in EMEA (2012-2017)
Figure Hytest Biodefense Revenue Market Share in EMEA (2012-2017)
Table GSK Biodefense Basic Information List
Table GSK Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GSK Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure GSK Biodefense Sales Market Share in EMEA (2012-2017)
Figure GSK Biodefense Revenue Market Share in EMEA (2012-2017)
Table Sanofi Biodefense Basic Information List
Table Sanofi Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi Biodefense Sales Market Share in EMEA (2012-2017)
Figure Sanofi Biodefense Revenue Market Share in EMEA (2012-2017)
Table PharmAthene Biodefense Basic Information List
Table PharmAthene Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure PharmAthene Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure PharmAthene Biodefense Sales Market Share in EMEA (2012-2017)
Figure PharmAthene Biodefense Revenue Market Share in EMEA (2012-2017)
Table Bavarian Nordic Biodefense Basic Information List
Table Bavarian Nordic Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bavarian Nordic Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Bavarian Nordic Biodefense Sales Market Share in EMEA (2012-2017)
Figure Bavarian Nordic Biodefense Revenue Market Share in EMEA (2012-2017)
Table SIGA Technologies Biodefense Basic Information List
Table SIGA Technologies Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure SIGA Technologies Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure SIGA Technologies Biodefense Sales Market Share in EMEA (2012-2017)
Figure SIGA Technologies Biodefense Revenue Market Share in EMEA (2012-2017)
Table Arbutus Biopharma Biodefense Basic Information List
Table Arbutus Biopharma Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Arbutus Biopharma Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Arbutus Biopharma Biodefense Sales Market Share in EMEA (2012-2017)
Figure Arbutus Biopharma Biodefense Revenue Market Share in EMEA (2012-2017)
Table DynPort Vaccine Biodefense Basic Information List
Table DynPort Vaccine Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure DynPort Vaccine Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure DynPort Vaccine Biodefense Sales Market Share in EMEA (2012-2017)
Figure DynPort Vaccine Biodefense Revenue Market Share in EMEA (2012-2017)
Table Xoma Corporation Biodefense Basic Information List
Table Xoma Corporation Biodefense Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Xoma Corporation Biodefense Sales (K MT) and Growth Rate (2012-2017)
Figure Xoma Corporation Biodefense Sales Market Share in EMEA (2012-2017)
Figure Xoma Corporation Biodefense Revenue Market Share in EMEA (2012-2017)
Table Ichor Medical Systems Biodefense Basic Information List
Table Aeolus Pharmaceuticals Biodefense Basic Information List
Table Achaogen Biodefense Basic Information List
Table Elusys Therapeutics Biodefense Basic Information List
Table Dynavax Technologies Biodefense Basic Information List
Table Cleveland BioLabs Biodefense Basic Information List
Table Soligenix Biodefense Basic Information List
Table Alnylam Pharmaceuticals Biodefense Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biodefense
Figure Manufacturing Process Analysis of Biodefense
Figure Biodefense Industrial Chain Analysis
Table Raw Materials Sources of Biodefense Major Manufacturers in 2016
Table Major Buyers of Biodefense
Table Distributors/Traders List
Figure EMEA Biodefense Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Biodefense Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biodefense Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Biodefense Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Biodefense Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biodefense Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biodefense Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biodefense Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Biodefense Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biodefense Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biodefense Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biodefense Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Biodefense Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biodefense Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biodefense Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biodefense Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Biodefense Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biodefense Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biodefense Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biodefense Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Biodefense Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biodefense Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Biodefense Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources